Your session is about to expire
← Back to Search
Fiber Supplements for Constipation in Parkinson's Disease (NRO Trial)
NRO Trial Summary
This trial will compare the effects of two types of fiber supplements on constipation in people with Parkinson's Disease.
NRO Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowNRO Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.NRO Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are currently taking a fiber supplement.My Parkinson's disease is not in the most advanced stage.I haven't taken drugs for my condition or am on a stable drug plan with no changes expected.I have been diagnosed with Parkinson's disease by a doctor.I have read and understood the consent form in English.I am being treated for a GI condition that is not constipation, gastroparesis, GERD, or diverticular disease.I can take the study treatment twice daily for 8 weeks.I am between 40 and 85 years old.You are very thin based on your height and weight.My condition is not typical Parkinson's but a variant form.You have difficulty swallowing the study supplement.I have been regularly using laxatives for the last month.
- Group 1: Coarse wheat bran
- Group 2: Maltodextrin
- Group 3: Psyllium
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
For what demographic is enrollment in this experiment open?
"This clinical trial seeks 79 volunteers suffering from Parkinson's disease, aged between 40 and 85. The mandatory requirements for the study include: no changes in PD medication dosage throughout the duration of the experiment; regular consumption of laxatives over the past month; a physician-confirmed diagnosis of PD; Hoehn & Yahr stage less than 4 in an "ON" state; comprehension and agreement to informed consent provided in English language; maintenance of habitual diet and exercise regimens during study period; twice daily intake of specified treatment over 8 weeks' time frame; completion of various questionnaires and dietary recalls within 10 week timeframe as well as vigorous adherence to"
Are there still opportunities for individuals to join the experiment?
"Affirmative, the clinical trial is actively recruiting. As seen on clinicaltrials.gov, this study was posted on May 13th 2021 and last updated September 14th 2022 in search of 79 participants at a singular site."
What is the approximate size of the cohort undergoing this research trial?
"Affirmative. The information provided on clinicaltrials.gov suggests that this medical experiment, which was posted in May 2021 and last edited in September 2022, is actively attempting to recruit 79 participants from a single location."
Is this investigation permitting elderly individuals to join?
"As per the restrictions outlined in this clinical trial's inclusion criteria, candidates must be between 40 and 85 years old."
Share this study with friends
Copy Link
Messenger